Clonal diversity of carbapenemase-producing multi-drug-resistant Klebsiella pneumoniae recovered from paediatric patients at Shenzhen, China

被引：0
|
作者：
Patil, S. [1 ]
Zhang, X. [2 ]
Pei-Gen, R. [3 ]
Wen, F. [2 ]
机构：
[1] Shenzhen Childrens Hosp, Heamatol & Oncol, Shenzhen, GZ, Peoples R China
[2] Shenzhen Childrens Hosp, Shenzhen, Peoples R China
[3] Shenzhen Inst Adv Technol, Dept Biomed Engn, Shenzhen, Peoples R China
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2020年 / 101卷
关键词：
D O I：
10.1016/j.ijid.2020.09.181
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
0138
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [41] Evaluation of In Vitro Activity of Ceftolozane-tazobactam and Ceftazidime-avibactam Against Carbapenemase-producing Multi-drug Resistant Klebsiella pneumoniae Isolates
    Terzi, Huseyin Agah
    Aydemir, Ozlem
    Demiray, Tayfur
    Koroglu, Mehmet
    Altindis, Mustafa
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2020, 9
  • [42] Evaluation of the synergistic effect of eravacycline and tigecycline against carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae
    Huang, Yu -Shan
    Yang, Jia-Ling
    Wang, Jann-Tay
    Sheng, Wang-Huei
    Yang, Chia-Jui
    Chuang, Yu -Chung
    Chang, Shan-Chwen
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (05) : 929 - 937
  • [43] Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae
    Jayol, Aurelie
    Nordmann, Patrice
    Poirel, Laurent
    Dubois, Veronique
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (02) : 542 - 544
  • [44] Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China
    Chen, Jinyun
    Wang, Dairong
    Ding, Yueping
    Zhang, Lei
    Li, Xi
    MICROBIAL DRUG RESISTANCE, 2019, 25 (02) : 251 - 257
  • [45] The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
    Jernigan, Meredith G.
    Press, Ellen G.
    Nguyen, M. Hong
    Clancy, Cornelius J.
    Shields, Ryan K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3395 - 3398
  • [46] Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae
    DeSarno, Alexandra E.
    Parcell, Benjamin J.
    Coote, Peter J.
    PATHOGENS AND DISEASE, 2020, 78 (09):
  • [47] Clonal, Plasmidic and Genetic Diversity of Multi-Drug-Resistant Enterobacterales from Hospitalized Patients in Tripoli, Libya
    Elgriw, Nada
    Metayer, Veronique
    Drapeau, Antoine
    Francois, Pauline
    Azaiez, Sana
    Mastouri, Maha
    Rhim, Hajer
    Elzagheid, Adam
    Soufiyah, Najeeb
    Madec, Jean-Yves
    Chaouch, Cherifa
    Mansour, Wejdene
    Haenni, Marisa
    ANTIBIOTICS-BASEL, 2023, 12 (09):
  • [48] An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread
    Weterings, V.
    Zhou, K.
    Rossen, J. W.
    van Stenis, D.
    Thewessen, E.
    Kluytmans, J.
    Veenemans, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (08) : 1647 - 1655
  • [49] Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae
    Falcone, M.
    Russo, A.
    Iacovelli, A.
    Restuccia, G.
    Ceccarelli, G.
    Giordano, A.
    Farcomeni, A.
    Morelli, A.
    Venditti, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (05) : 444 - 450
  • [50] Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
    Seo, Hyeonji
    Bae, Seongman
    Kim, Min Jae
    Chong, Yong Pil
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Jung, Jiwon
    INFECTION AND CHEMOTHERAPY, 2021, 53 (03): : 528 - 538
12345